Letermovir: an enticing new CMV prophylaxis option with growing evidence in heart and lung transplantation. Skeggs JL, Gardiner BJ. J Heart Lung Transplant 2025 Sep 25:S1053-2498(25)02281.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Skeggs JL, Gardiner BJ. Letermovir: an enticing new CMV prophylaxis option with growing evidence in heart and lung transplantation. J Heart Lung Transplant 2025 Sep 25:S1053-2498(25)02281.
PMID: 41015400